Choose Your Location
|
![]() |
CORONA, Calif. (Map) -
Omeprazole is the generic equivalent to AstraZeneca's Prilosec(R)
Delayed-Release Capsules USP and is indicated for the short-term treatment of
active duodenal ulcer. For the 12-months ending
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.
Forward-Looking Statement
Any statements contained in this press release that refer to future events
or other non-historical facts are forward-looking statements that reflect
Watson's current perspective of existing trends and information as of the date
of this release. Except as expressly required by law, Watson disclaims any
intent or obligation to update these forward-looking statements. Actual
results may differ materially from Watson's current expectations depending
upon a number of factors affecting Watson's business. These factors include,
among others, the impact of competitive products and pricing; market
acceptance of and continued demand for Watson's products; and other risks and
uncertainties detailed in Watson's periodic public filings with the Securities
and Exchange Commission, including but not limited to Watson's Annual Report
on Form 10-K for the year ended
Prilosec(R) is a registered trademark of the AstraZeneca group of companies.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
|
|


